|
Journalists:
please note that all presentations are embargoed until the
time of their actual presentation at the Late Breaking Clinical
Trial (LBCT) sessions. The date and time of each official
presentation at an LBCT session is provided at the end of
each trial topic description.
Highlights
from:
SUNDAY | MONDAY | TUESDAY
| WEDNESDAY
SUNDAY,
MARCH 17
Results from
Sunday
7:40
a.m. - 8:45 a.m.
ACC Opening Media Briefing
Presenters:
ACC President Dr. Douglas P. Zipes, ACC '02 Program Committee
Chair Dr. Eric S. Williams, and ACC '02 Program Committee
Co-chair Dr. John M. Miller of Indiana University School of
Medicine, Indianapolis.
 Listen
to the news conference.
10:30
a.m. - 11:15 a.m.
Percutaneous Coronary Intervention
General
- A
Double-Blind, Placebo-Controlled, Randomized Trial of Fluvastatin
After Successful Percutaneous Intervention (PCI) in Patients
With Coronary Heart Disease: The Lescol Intervention Prevention
Study (LIPS)—Patrick W. Serruys, MD, FACC, Erasmus
University, Rotterdam, Netherlands, 3/20, 8:30 a.m., #421
- Impact
of Clinical Syndrome Acuity on the Differential Response
to Two Glycoprotein IIb/IIIa Inhibitors on Patients Undergoing
Coronary Stenting: The TARGET Trial—Gregg W. Stone,
MD, FACC, Lenox Hill Heart and Vascular Institute, New York,
NY, 3/17, 5:15 p.m., #0032-6
- Early
and Sustained Survival Benefit Associated With Statin Therapy
at the time of Percutaneous Coronary Intervention—Albert
W. Chan, MD, The Cleveland Clinic Foundation, Cleveland,
Ohio, 3/17, 3:00 p.m., #1053-1
- Emergency
CABG After Failed PCI in Contemporary Practice: A Report
From the ACC-NCDR™ Registry—Lloyd
W. Klein, MD, FACC, St. Luke's Medical Center, Chicago,
Illinois, 3/18, 3:00 p.m., #1125-7
Moderator:
George Ventrovec, MD, FACC, Medical College of Virginia
Listen
to the news conference.
11:30
a.m. - 12:15 p.m.
Percutaneous Coronary Intervention
Coated Stents
- Safety
and Feasibility of a Tacrolimus-Coated Drug-Eluting Stent:
Short- and Mid-Term Results of a Tacrolimus-Coated Drug-Eluting
Stent: Short- and Mid-Term Results of Both the PRESENT and
the EVIDENT Trial—Peter
Fitzgerald, MD, FACC, Stanford, Calif., 3/17, 8:45 a.m.,
#22 (speaker not present)
- Heparin-Coated
Stents in Small Coronary Arteries: Results of the COAST
Trial—Michael Haude, MD, Med.Klinik II, UKL, Essen,
Germany, 3/17, 8:45 a.m., #22
- 210-Day
Follow-up of the RAVEL Study: A Randomized Study with the
Sirolimus-Eluting Bx VELOCITY™ Balloon-Expandable Stent
in the Treatment of Patients With De Novo Native Coronary
Artery Lesions—Jean Fajadet, MD, Clinique Pasteur,
Toulouse, France, 3/17, 4:00 p.m., #0032-1
- Late
(Two-Year) Follow-Up From the First-in-Man (FIM) Experience
After Impantation of Sirolimus-Eluting Stents—Jose
Eduardo Sousa, MD, FACC, Institute Dante Pazzanese of Cardiology,
San Paulo, Brazil, 3/17, 4:30 p.m., #0032-3
- Sirolimus-Eluting
Stents Abolish Neointimal Hyperplasia in Patients With In-Stent
Restenosis: Late Angiographic and Intravascular Ultrasound
Results—Patrick
W. Serruys, MD, FACC, Erasmus University, Rotterdam, Netherlands,
3/18, 2:00 p.m., #823-1
- Safety
and Performance of a Paclitaxel-Eluting Stent for the Treatment
of In-Stent Restenosis: Preliminary Results of the Taxus
III Trial—Gregg
W. Stone, MD, FACC, Lenox Hill Heart and Vascular Institute,
New York, NY, 3/19, 12:00 p.m., #1174-15
- Oral
Sirolimus for Recalcitrant In-Stent Restenosis—Paul
S. Teirstein, MD, FACC, Scripps Clinic, La Jolla, Calif.,
3/18, 2:30 p.m., #823-3
Moderator:
Spencer King, MD, MACC, Cardiology of Georgia, Atlanta
Listen
to the news conference.
MONDAY,
MARCH 18
Results from Monday
8:15
a.m. - 9:00 a.m.
Heart Failure
- Cardiac
Resynchronization Therapy Reduces Morbidity in Patients
With Moderate to Severe Systolic Heart Failure and Intraventricular
Conduction Delays—William T. Abraham, MD, FACC,
University of Kentucky, Lexington, Kentucky, 3/18, 4:15
p.m., #839-2
- Cardiac
Resynchronization Reverses Left Ventricular Remodeling and
Reduces Cytokine Activation in Patients With Dilated Cardiomyopathy
and Left Bundle Branch Block—William T. Abraham,
MD, FACC, University of Kentucky, Lexington, Kentucky, 3/17,
10:00 a.m., #1017-119
- Upgrade
to Biventricular Pacing in Advanced Heart Failure Patients
Previously Implanted With a Conventional Pacemaker for a
Classical Indication: Is It Worth It?—Jean-Claude
Daubert, Chu Pontchaillou Centre Cariopn, Rennes, France,
3/18, 11:30 a.m., #815-3
- Effects
of the Endothelin Receptor Antagonist Bosentan on the Morbidity
and Mortality in Patients With Chronic Heart Failure: Results
of the ENABLE 1 and 2 Trial Program—Milton Packer,
MD, FACC, Columbia Presbyterian Medical Center, New York,
NY, 3/19, 8:30 a.m., #412
Moderator:
Sharon Hunt, MD, FACC, Stanford University Medical Center,
Palo Alto, Calif.
Listen
to the news conference.
11:00
a.m. – 11:45 a.m.
Prevention and Treatment of
Atrial Fibrillation
- Survival
in Patients Presenting With Atrial Fibrillation: The Atrial
Fibrillation Follow-Up Investigation of Rhythm Management
(AFFIRM) Study—George Wyse, MD, PhD, FACC, University
of Calgary, Canada, 3/18, 9:15 a.m., #405
- Rate
Control vs. Electrical Cardioversion for Persistent Atrial
Fibrillation. A Randomized Comparison of Two Treatment Strategies
Concerning Mortality and Morbidity: The RACE Study—Harry
J. Crijins, MD, FESC, University Hospital Maastrict, Netherlands,
3/18, 9:15 a.m., #405
- Focal
vs. Isolation Ablation of Pulmonary Vein Triggers for Atrial
Fibrillation: Short-Term Outcome—Francis E. Marchlinski,
MD, FACC, University of Pennsylvania, Philadelphia, PA,
3/20, 9:45 a.m., #885-6
- Pulmonary
Veins Isolation for Treatment of Atrial Fibrillation in
Patients With Impaired Left Ventricular Function—Nassir
F. Marrouche, MD, The Cleveland Clinic Foundation, Cleveland,
Ohio, 3/20, 9:00 a.m., #885-3
Moderator:
Anne Curtis, MD, FACC, University of Florida, Gainesville,
Fla.
Listen
to the news conference.
12:00
p.m. – 12:45 p.m.
Diabetes
- Exposure
to Glitazone Antidiabetics and Risk of Heart Failure Among
Persons With Type 2 Diabetes: A Retrospective Population-Based
Cohort Analysis—Mr. Thomas Delea, Policy Analysis,
Inc., Brookline, Mass., 3/19, 11:00 a.m., #858-3
- Dramatic
Increase in 30-Day Mortality in Diabetic Patients With Non-ST
Segment Elevation Acute Coronary Sydromes—Marco
Roffi, MD, Cleveland Clinic Foundation, Cleveland, Ohio,
3/19, 9:15 a.m., #840-4
- Improving
Outcome in Treatment of Diabetics With ST Elevation Myocardial
Infarction: Insights from the GUSTO Trials—Hitinder
S. Gurm, MD, Cleveland Clinic Foundation, Cleveland, Ohio,
3/18, 10:00 a.m., #1074-33
- Make
the Link! patient survey results—John
Buse, MD, PhD, CDE, FACC, University of North Carolina School
of Medicine,Chapel Hill, on behalf of the American Diabetes
Association
Moderator:
Robert Rosenson, MD, FACC, University of Florida, Gainesville,
Fla.
Listen
to the news conference.
1:45
p.m. – 2:30 p.m.
ACCardio Unveiled at ACC'02
Presenters:
- Shahir
Kassam-Adams, Elsevier Science, Inc., Health Sciences Division,
New York City
- Kim
A. Eagle, MD, FACC, University of Michigan Medical Center,
Ann Arbor, Mich.
Moderator:
Douglas P. Zipes, MD, FACC, Krannert Institute of Cardiology,
Indianapolis
Listen
to the news conference.
TUESDAY,
MARCH 19
Results from Tuesday
7:30
a.m. - 8:15 a.m.
Heart Disease Risk Factors and
Prevention
- The
National Cholesterol Education Program Guidelines Underestimate
Disease Risk in Young Adults—Paul M. Schoenfeld,
MD, FACC, Gundersen Clinic, Las Crosse, Wisc., 3/19, 12:00
p.m., #1179-76
- The
Metabolic Score Predicts Subclinical Atherosclerosis Independent
of Fasting Serum LDL: Evidence Supporting Inclusion of the
Metabolic Syndrome as a Component Within the NCEP ATP III
Guidelines —Marc E. Hunt, MD, Walter Reed Army
Medical Center, Washington, D.C., 3/19, 12:00 p.m., #1179-77
- Adult
High Density Lipoprotein Cholesterol Has Decreased Ten Percent
in the Past 25 Years: The Princeton Follow-Up Study—John
A. Morrison, MD, Children's Hospital, Cincinnati, Ohio,
3/19, 12:00 p.m., #1179-78
- Echocardiography
Predicts Early Cardiovascular Risk in a Population of Normal
Young Adult Women—Thomas
Kimball, MD, Children's Hospital, Cincinnati, Ohio, 3/17,
4:36 p.m., #1062MP-129
- Body
Composition and Prognosis in Chronic Systolic Heart Failure:
The Obesity Paradox—Carl
J. Lavie, MD, FACC, Ochsner Medical Institutions, New Orleans,
La., 3/19, 2:45 p.m., #869-4
Moderator:
Richard Pasternak, MD, FACC, Massachusetts General Hospital,
Boston, Mass.
Listen
to the news conference.
10:30
a.m. - 11:15 a.m.
Blood Markers—B-Type
Natriuretic Peptide
- A
Prospective, Blinded Trial of B-Type Natriuretic Peptide
as a Diagnosis Test for the Emergency Diagnosis of Heart
Failure: The Breathing Not Properly (BNP) Multinational
Study—Peter A. McCullough, MD, MPH, FACC, Truman
Medical Center, Kansas City, Mo., 3/19, 8:30 a.m., #412
- Primary
Results of the BNP Multinational Study: B-Type Natriuretic
Peptide in the Emergency Diagnosis of Heart Failure—Alan
S. Maisel, MD, FACC, San Diego VA Healthcare, La Jolla,
CA., 3/17, 11:45 a.m., #895-6
- Plasma
N-Terminal pro-BNP Predicts the Occurrence of Major Clinical
Events in Severe Chronic Heart Failure: Results of a Substudy
of the COPERNICUS Trial—Franz S. Hartmann, MD,
Medical Klinik II, UKL, Germany, 3/20, 10:30 a.m., #895-1
- Echocardiography
Predicts Early Cardiovascular Risk in a Population of Normal
Young Adult Women—Thomas
Kimball, MD, Children's Hospital, Cincinnati, Ohio, 3/17,
4:36 p.m., #1062MP-129
- Body
Composition and Prognosis in Chronic Systolic Heart Failure:
The Obesity Paradox—Carl
J. Lavie, MD, FACC, Ochsner Medical Institutions, New Orleans,
La., 3/19, 2:45 p.m., #869-4
Moderator:
Margaret Redfield, MD, FACC, Mayo Clinic, Rochester, Minn.
Listen
to the news conference.
11:30
a.m. - 12:15 p.m.
Quality of Care
- Effectiveness
of Quality Improvement Initiative (Guidelines Applied to
Practice [GAP] Project) in Improving the Care of Medicare
Patients and Women With Acute Myocardial Infarction—Rajendra
H. Mehta, MD, University of Michigan Health System, Ann
Arbor, Mich., 3/19, 9:15 a.m., #849-4
- Is
Early Hospital Discharge Following Acute Myocardial Infarction
Associated With Increased Mortality?—Alan K. Berger,
MD, University of Minnesota, Minneapolis, Minn., 3/19, 8:45
a.m., #861-1
- Quality
of Care of Patients Admitted With Congestive Heart Failure:
Influence of Physician Specialty and Hospital Type—Jay
K. Amin, MD, University of Michigan, Ann Arbor, 3/19, 8:45
a.m., #849-2
- Is
Quality of Life Enhanced in Octogenarians Undergoing Coronary
Artery Bypass Surgery?—Paul
Kurlansky, MD, FACC, Miami Heart Research Institute, Miami,
Fla., 3/19, 9:00 a.m., #847-3
Moderator:
Raymond J. Gibbons, MD, FACC, Nuclear Cardiology Lab, Mayo
Clinic, Rochester, Minn.
Listen
to the news conference.
12:30
p.m. - 1:15 p.m.
Defibrillators
- Improved
Survival With Prophylactic ICD Therapy in Patients With
Prior Myocardial Infarction and Reduced Left Ventricular
Ejection Fraction—Arthur J. Moss, MD, FACC, University
of Rochester Medical Center, Rochester, N.Y., 3/19, 8:30
a.m., #412
- Results
of the InSync ICD Clinical Trial—James B. Young,
MD, FACC, The Cleveland Clinic Foundation, Cleveland, Ohio,
3/20, 8:30 a.m., #421
- New
Therapeutic Option for Patients With Time-Dependent Risk
of Sudden Cardiac Arrest: Application of Novel Wearable
Cardioverter-Defibrillator—Arthur M. Feldman, MD,
PhD, FACC, University of Pittsburgh School of Medicine,
Pittsburgh, Pa., 3/18, 2:00 p.m., #826-1
- Flight
Attendant Response to AED Instruction: Results of a Survey
and Implications for Training Public Access Defibrillation—Richard
L. Page, MD, FACC, University of Texas Southwestern Medical
Center, Dallas, Texas, 3/17, 10:00 a.m., #1003-33
- Early
Defibrillation Training Courses for Lay Volunteers Without
Cardiopulmonary Resuscitation Education: The Piacenza Progetto
Vita Experience—Alessandro
Capucci, MD, FACC, Ospedale Clinic, Piacenza, Italy, 3/17,
10:00 a.m., #1003-37
- Broad
Dissemination of Automatic External Defibrillators Triples
Sudden Cardiac Arrest Survival in a Medium-Size Town—Alessandro
Capucci, MD, FACC, Ospedale Clinic, Piacenza, Italy, 3/19
4:15 p.m., #870-2
Moderator:
Douglas P. Zipes, MD, FACC, ACC president and Indiana University
School of Medicine, Indianapolis, Indiana
Listen
to the news conference.
WEDNESDAY,
MARCH 20
Results from Wednesday
7:30
a.m. - 8:15 a.m.
Gender, Age, and Race
- Gregg
W. Stone, MD, FACC, Lenox Hill Heart and Vascular Institute,
New York, N.Y., Primary Stenting Optimizes the Outcome
of Women With Acute Myocardial Infarction: Results From
the CADILLAC Trial (3/18, 2:15 p.m., #824FO-2)
- Milton
Packer, MD, FACC, Omapatrilat Versus Enalapril Randomized
Trial of Utility in Reducing Events (OVERTURE)
- Matthias
Pfisterer, MD, FACC, University Hospital, Basel, Switzerland,
Outcome of Elderly Women With Refractory Chronic Angina
Treated Invasively Versus Medically: Comparison With Elderly
Men in the Prospective Randomized Trial of Invasive Versus
Medical Therapy in the Elderly (TIME) (3/19, 9:45 a.m.,
#847-6)
- Marc
S. Sabatine, MD, Brigham & Women’s Hospital, Boston,
Mass., Nonwhite Race Is Associated With a Higher Rate of
Death and Ischemic Complications in Patients With Acute
Coronary Syndromes Despite Modern Early Invasive Treatment
(3/19, 8:30 a.m., #840-1)
Moderator:
C. Noel Bairey Merz, MD, FACC, Cedar-Sinai Medical Center,
Los Angeles, Calif.
Listen
to the news conference.
|
